21.03.2014
- Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...
03.03.2014
- Generic drugmakers are actively campaigning against a rule proposed by the U.S. Food and Drug Administration (FDA) that would require them to change the prescribing information on...
21.02.2014
- Dublin, Ireland-based generic drugmaker Actavis is acquiring specialty pharmaceuticals company Forest Laboratories of New York in a cash and stock deal valued at about $25 billion...
11.02.2014
- German generic drugmakers are annoyed at plans by the new Christian and Social Democrat coalition government to increase the mandatory rebate afforded the country's national...
27.01.2014
- Indian drugmaker Ranbaxy Laboratories faces long delays and high costs in launching big-selling generic drugs in the U.S. after products from a fourth plant were banned due to...
13.12.2013
- The European Commission has fined U.S. pharmaceutical producer Johnson & Johnson (J&J) €10.8 million and Swiss drugmaker Novartis of Switzerland € 5.5 million for actions taken by...
31.10.2013
- Trial And Error - Despite a 150-year history and an aggregate R&D expenditure of $150 billion per year, innovation in the modern pharmaceutical industry is essentially still based...
30.10.2013
- 'Pharmacy To The World' - In today's global pharmaceutical industry 2.0, emerging regions led by India (BRIC - Brazil, Russia, India, China) have moved to the front row in terms of...
